4//SEC Filing
Jones Mitchell Lawrence 4
Accession 0001493152-24-005482
CIK 0001357459other
Filed
Feb 7, 7:00 PM ET
Accepted
Feb 8, 4:38 PM ET
Size
14.1 KB
Accession
0001493152-24-005482
Insider Transaction Report
Form 4
Jones Mitchell Lawrence
Chief Medical Officer
Transactions
- Exercise/Conversion
Restricted Stock Units
2024-02-06−4,558→ 45,586 total→ Common Stock (4,558 underlying) - Exercise/Conversion
Common Stock, par value $0.01
2024-02-06+2,333→ 9,815 total - Exercise/Conversion
Common Stock, par value $0.01
2024-02-06+4,558→ 7,482 total - Exercise/Conversion
Restricted Stock Units
2024-02-06−2,333→ 25,667 total→ Common Stock (2,333 underlying) - Tax Payment
Common Stock, par value $0.01
2024-02-06$0.44/sh−2,153$939→ 7,662 total
Footnotes (6)
- [F1]Represents the issuance of common stock upon the vesting and settlement of outstanding restricted stock units for the restricted stock units granted on September 5, 2023.
- [F2]Represents the issuance of common stock upon the vesting and settlement of outstanding restricted stock units for the restricted stock units granted on November 21, 2023.
- [F3]Represents shares sold on behalf of Reporting Person to satisfy tax requirements related to the vesting of the restricted stock units for each of the vested portions of the grant.
- [F4]Each restricted stock unit represents the right to receive, at settlement, one share of common stock.
- [F5]This restricted stock unit was granted on September 5, 2023, and 4,558 restricted stock units subject to the award vested on February 6, 2024, and an additional 45,586 restricted stock units will vest in equal quarterly installments over the remaining portion of the three-year period from the grant date, subject to Reporting Person continuing to be a service provider to Issuer at the time of vesting.
- [F6]This restricted stock unit was granted on November 21, 2023, and 2,333 restricted stock units subject to the award vested on February 6, 2024, and an additional 25,667 restricted stock units will vest in equal quarterly installments over the remaining portion of the three-year period from the grant date, subject to Reporting Person continuing to be a service provider to Issuer at the time of vesting.
Documents
Issuer
PALISADE BIO, INC.
CIK 0001357459
Entity typeother
Related Parties
1- filerCIK 0001993292
Filing Metadata
- Form type
- 4
- Filed
- Feb 7, 7:00 PM ET
- Accepted
- Feb 8, 4:38 PM ET
- Size
- 14.1 KB